Apixaban Intermediate CAS 503615-03-0 3-Morpholino-1- (4-Nitrophenyl) -5,6-Dihydropyridin-2 (1H) -otu ịdị ọcha ≥99.0% (HPLC)

Nkọwa dị mkpirikpi:

3-Morpholino-1- (4-Nitrophenyl) -5,6-Dihydropyridin-2 (1H) - otu.

Nọmba ekwentị: 503615-03-0

Dị ọcha: ≥99.0% (HPLC)

Ọdịdị: Yellow Powder

Ọkara nke Apixaban (CAS: 503612-47-3)

Kpọtụrụ: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Ruifu Chemical bụ onye na-emepụta ihe na-emepụta 3-Morpholino-1- (4-Nitrophenyl) -5,6-Dihydropyridin-2 (1H) -otu (CAS: 503615-03-0) na elu mma.Ruifu Chemical nwere ike ịnye nnyefe zuru ụwa ọnụ, ọnụahịa asọmpi, ọrụ magburu onwe ya, obere na nnukwu ọnụọgụ dị.Ịzụta ndị etiti Apixaban,Please contact: alvin@ruifuchem.com

Apixaban Intermediates:

Njirimara kemịkalụ:

Aha Chemical 3-Morpholino-1- (4-Nitrophenyl) -5,6-Dihydropyridin-2 (1H) - otu.
Ụdị okwu 3- (4-Morpholinyl) -1- (4-Nitrophenyl) -5,6-Dihydro-2 (1H) -Pyridinone;5,6-Dihydro-3- (4-Morpholinyl) -1- (4-Nitrophenyl) -2 (1H) -Pyridinone;Apixaban Intermediate 3;Apixaban adịghị ọcha 36;Usoro Apixaban adịghị ọcha 1
Ọnọdụ Ahịa Na ngwaahịa, Mmepụta Azụmahịa
Nọmba CAS 503615-03-0
Usoro ihe omimi C15H17N3O4
Ibu molekụla 303.31 g/mol
Ebe Na-agbaze 165.0 ~ 170.0 ℃
Ebe esi nri 506.5± 50.0 ℃
Njupụta 1.357g/mL
COA & MSDS Dị
Mmalite Shanghai, China
Otu Ọkara nke Apixaban (CAS: 503612-47-3)
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Ụkpụrụ nyocha Nsonaazụ
Ọdịdị Ntụ ntụ odo Ntụ ntụ odo
Ebe Na-agbaze 165.0 ~ 170.0 ℃ 167.0 ~ 170.0 ℃
Ọnwụ na ihicha ≤0.50% 0.3%
Ọdịghị ọcha nke Onwe Onye (Max.) ≤0.50% 0.3%
Mgbakọta adịghị ọcha ≤1.00% 0.6%
Ụzọ ịdị ọcha / nyocha ≥99.0% (HPLC) 99.4%
1 H NMR Spectrum Nkwekọ na Structure Na-akwado
LC/MS Nkwekọ na Structure Na-akwado
Mmechi A nwalela ngwaahịa a wee kwado nkọwa ndị enyere

Ngwugwu/Nkwakọba/Mbupu:

ngwugwu:Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Debe akpa ahụ nke ọma ma chekwaa n'ebe dị jụụ, kpọrọ nkụ (2 ~ 8 ℃) yana ụlọ nkwakọba ihe nke ọma na-esi na ihe ndị na-adabaghị adaba.Chebe site na ìhè na mmiri mmiri.
Mbupu:Jiri ikuku na-ebuga ụwa niile site na FedEx / DHL Express.Nye nnyefe ngwa ngwa na ntụkwasị obi.

503615-03-0 - Ụzọ sịntetik:

www.ruifuchemical.com

Uru:

Ike zuru oke: akụrụngwa na ndị ọrụ nka zuru oke

Ọrụ Ọkachamara: Otu nkwụsị ịzụrụ ọrụ

Ihe ngwugwu OEM: ngwugwu omenala na akara dị

Nnyefe ngwa ngwa: Ọ bụrụ n'ime ngwaahịa, ekwenyere nnyefe ụbọchị atọ

Nkwanye kwụsiri ike: Jikwaa ngwaahịa ezi uche dị na ya

Nkwado nka na ụzụ: Ngwọta teknụzụ dị

Ọrụ Synthesis Custom: sitere na gram ruo kilos

Ogo dị elu: guzobe usoro mmesi obi ike zuru oke

Ajụjụ:

Kedu ka esi azụta?Biko kpọtụrụDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

Ahụmịhe afọ 15?Anyị nwere ihe karịrị 15 afọ nke ahụmahụ na mmepụta na mbupụ nke a dịgasị iche iche nke elu mma pharmaceutical intermediates ma ọ bụ ezi kemịkal.

Isi ahịa?Na-ere ahịa ụlọ, North America, Europe, India, Korea, Japanese, Australia, wdg.

Uru?Ogo kachasị elu, ọnụ ahịa dị ọnụ ala, ọrụ ọkachamara na nkwado teknụzụ, nnyefe ngwa ngwa.

OgoNkwenye?Usoro njikwa mma siri ike.Ngwá ọrụ ọkachamara maka nyocha gụnyere NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, wdg.

Ihe atụ?Ọtụtụ ngwaahịa na-enye ihe nlele efu maka nyocha dị mma, ndị ahịa kwesịrị ịkwụ ụgwọ mbupu.

Nyocha ụlọ ọrụ?Nnabata nyocha ụlọ ọrụ.Biko mee oge oge tupu oge eruo.

MOQ?Enweghị MOQ.A na-anabata obere usoro.

Oge Mbuga ozi? Ọ bụrụ n'ime ngwaahịa, ekwenyere nnyefe ụbọchị atọ.

Ụgbọ njem?Site Express (FedEx, DHL), nke ikuku, site n'oké osimiri.

Akwụkwọ?Mgbe ọrụ ahịa gasịrị: COA, MOA, ROS, MSDS, wdg nwere ike ịnye.

Synthesis omenala?Nwere ike ịnye ọrụ nhazi ahaziri iche ka ọ dabara mkpa nyocha gị nke ọma.

Usoro ịkwụ ụgwọ?A ga-ebu ụzọ ziga akwụkwọ ọnụahịa Proforma mgbe nkwenye nke iwu, kpuchiri ozi ụlọ akụ anyị.Ịkwụ ụgwọ site na T/T (Telex Nyefee), PayPal, Western Union, wdg.

Ngwa:

3-Morpholino-1- (4-Nitrophenyl) -5,6-Dihydropyridin-2 (1H) -otu (CAS: 503615-03-0) bụ etiti maka njikọ nke Apixaban (CAS: 503612-47-3) .
Apixaban bụ ụdị ọhụrụ nke inhibitor Xa factor inhibitor nke Bristol-Myers Squibb na Pfizer mebere.Aha ahia a bu Eratol, nke bu udi ohuru nke anticoagulant nke onu.Site na igbochi ihe dị mkpa coagulation Xa, Apixaban nwere ike igbochi mmepụta thrombin na thrombosis.
N'April 26, 2007, Bristol-Myers Squibb sonyeere Pfizer aka ikwusa nkwado na mmepe nke ọhụrụ anticoagulant Apixaban nke Bristol-Myers Squibb nwere dị ka ihe nkwalite ọzọ na warfarin.Dị ka nkwekọrịta imekọ ihe ọnụ, Pfizer ga-akwụ ụgwọ tupu ugwo nke US $ 0.25 ijeri na Bristol-Myers Squibb iji buru 60% nke mkpokọta mmepe nke anticoagulant Apixaban (a ga-emejuputa ya site na Jenụwarị 1, 2007), ebe Bristol-Myers. Squibb ga-ebu 40% fọdụrụnụ, si otú a na-enweta ikike ijikọ mmepụta na ire ọgwụ ahụ.
Na May 2011, Apixaban bụ onye mbụ kwadoro mgbochi nke thrombosis venous na ndị ọrịa toro eto na-ahọrọ ịwa ahụ hip ma ọ bụ ikpere na mba 27 EU, Iceland na Norway.
Na Nọvemba 20, 2012, European Commission kwadoro Ererto (Apixaban) maka igbochi ọrịa strok na usoro embolism na ndị okenye na-arịa ọrịa na-adịghị valvular atrial fibrillation (NVAF) na otu ma ọ bụ karịa ihe ize ndụ.N'ikpeazụ, Canadian Food and Drug Administration, Japan, na US FDA kwadoro Ererto (Apixaban) maka mgbochi nke ọrịa strok na embolism systemic na ndị ọrịa toro eto na-enweghị valvular atrial fibrillation (NVAF) nwere otu ma ọ bụ karịa ihe ize ndụ.
N'April 12, 2013, a mara ọkwa ọkwa ọgwụ ọhụrụ anticoagulant Eloto (ELIQUIS)(apixaban) nke Bristol-Myers Squibb na Pfizer mebere na China.Ererto bụ ihe na-egbochi ọnụ Xa inhibitor maka mgbochi nke venous thromboembolism (VTE) n'ime ndị ọrịa toro eto na-anata ngbanwe hip ma ọ bụ ikpere.Ndepụta ya na-enye nhọrọ ọhụrụ dị mma ma dị irè maka ọgwụ mgbochi ọrịa ọgwụ mgbe a wachara ahụ ọkpụkpụ, ma na-ewetara ndị ọrịa China na-eme mgbanwe mgbanwe hip / ikpere.Nnyocha ụlọ ọgwụ ekwenyela na e jiri ya tụnyere 40mg enoxaparin otu ugboro n'ụbọchị, nchịkwa ọnụ nke Eratol (Apixaban) 2.5mg ugboro abụọ n'ụbọchị dị irè karị maka igbochi thromboembolism venous mgbe ịwa ahụ dochie hip ma ọ bụ ikpere, na ọ dịghị eme ka ohere nke ọbara ọgbụgba dịkwuo elu.

Dee ozi gị ebe a ziga anyị ya